TITLE

Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis

AUTHOR(S)
Mimura T; Rizzello F; Helwig U; Poggioli G; Schreiber S; Talbot I C; Nicholls R J; Gionchetti P; Campieri M; Kamm M A
PUB. DATE
January 2004
SOURCE
Gut;Jan2004, Vol. 53 Issue 1, p108
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
BACKGROUND: Ten to 15% of patients with pouchitis experience refractory or recurrent disease. The aim of this study was to evaluate the effectiveness of a single daily high dose probiotic preparation (VSL#3) in maintaining antibiotic induced remission, and quality of life (QOL), for one year in such patients. METHODS: Patients with pouchitis at least twice in the previous year or requiring continuous antibiotics, associated with a pouchitis disease activity index (PDAI) > or =7 (0 = perfect; 18 = worst), in whom remission was induced by four weeks of combined metronidazole and ciprofloxacin, were randomised to receive VSL#3 6 g or placebo once daily for one year or until relapse. Symptomatic, endoscopic, and histological evaluations were made before, and two and 12 months after randomisation or at the time of relapse. Remission was defined as a clinical PDAI < or =2 and endoscopic PDAI < or =1. Relapse was defined as an increased clinical PDAI score > or =2 and increased endoscopic PDAI score > or =3. QOL was assessed using the inflammatory bowel disease questionnaire (IBDQ). RESULTS: Thirty six patients were randomised: 20 to VSL#3 and 16 to placebo. Remission was maintained at one year in 17 patients (85%) on VSL#3 and in one patient (6%) on placebo (p<0.0001). The IBDQ score remained high in the VSL#3 group (p = 0.3) but deteriorated in the placebo group (p = 0.0005). CONCLUSION: The once daily high dose probiotic VSL#3 is effective in maintaining antibiotic introduced remission for at least a year in patients with recurrent or refractory pouchitis. This is associated with a high level of quality of life.
ACCESSION #
12136748

 

Related Articles

  • Drug therapy: dose-response relationship of oral mesalazine in inflammatory bowel disease. Mulder, C. J. J.; Hazel, S. J. Van Den // Mediators of Inflammation;Jun98, Vol. 7 Issue 3, p135 

    MESALAZINE is widely used in the treatment of inflammatory bowel disease. Little is known about the doseresponse relationship and about possible dose related side effects. In ulcerative colitis higher dosages of mesalazine (3 g) are more effective in maintaining a remission than lower dosages...

  • Lactobacillus Paracasei subsp. Paracasei F19; a farmacogenomic and clinical update. Di Cerbo, Alessandro; Palmieri, Beniamino // Nutricion Hospitalaria;nov/dic2013, Vol. 28 Issue 6, p1842 

    Introduction: Many reports in literature have underlined particular features of Lactobacillus paracasei subsp paracasei F19, however a critical review of main clinical outcomes has not been performed so far. Objectives: This review summarizes the most relevant reports, in terms of clinical...

  • Antibiotics Associated With Increased Risk of New-Onset Crohn's Disease But Not Ulcerative Colitis: A Meta-Analysis. Ungaro, Ryan; Colombel, Jean-Frédéric; Atreja, Ashish; Bernstein, Charles N; Shaw, Souradet; Gearry, Richard; Hviid, Anders; Kolho, Kaija-Leena; Kronman, Matthew P; Van Kruiningen, Herbert // American Journal of Gastroenterology;Nov2014, Vol. 109 Issue 11, p1728 

    OBJECTIVES:The objective of this study was to perform a meta-analysis investigating antibiotic exposure as a risk factor for developing inflammatory bowel disease (IBD).METHODS:A literature search using Medline, Embase, and Cochrane databases was performed to identify studies providing data on...

  • Reacciones inmunológicas a los antibióticos más frecuentemente utilizados.  // Revista de la Facultad de Medicina de la UNAM;Sep/Oct2012, Vol. 55 Issue 5, p55 

    No abstract available.

  • Failure of antibiotic treatment in microbial populations. De Leenheer, Patrick; Cogan, N. G. // Journal of Mathematical Biology;Oct2009, Vol. 59 Issue 4, p563 

    The tolerance of bacterial populations to biocidal or antibiotic treatment has been well documented in both biofilm and planktonic settings. However, there is still very little known about the mechanisms that produce this tolerance. Evidence that small, non-mutant subpopulations of bacteria are...

  • Quantitative Models of the Dose-Response and Time Course of Inhalational Anthrax in Humans. Toth, Damon J. A.; Gundlapalli, Adi V.; Schell, Wiley A.; Bulmahn, Kenneth; Walton, Thomas E.; Woods, Christopher W.; Coghill, Catherine; Gallegos, Frank; Samore, Matthew H.; Adler, Frederick R. // PLoS Pathogens;Aug2013, Vol. 9 Issue 8, p1 

    Anthrax poses a community health risk due to accidental or intentional aerosol release. Reliable quantitative dose-response analyses are required to estimate the magnitude and timeline of potential consequences and the effect of public health intervention strategies under specific scenarios....

  • STANDARDIZATION OF SELECTIVE LETHAL DOSE OF ANTIBIOTICS (HYGROMYCIN AND PAROMOMYCIN) FOR SELECTION OF TRANSGENICS IN DURUM WHEAT. VERMA, L.; BAINS, N. S.; GOSAL, S. S. // Journal of Cell & Tissue Research;2014, Vol. 14 Issue 3, p4671 

    In transformation process antibiotic resistance genes are introduced along with the gene of interest and used for selecting the transformed cells from the non-transformed ones. Selective lethal dose of two antibiotics i.e. hygromycin and paromomycin was standardized for three durum wheat...

  • Treatment of Respiratory Infections in Children with Methacycline. Bumbalo, Thos. S.; Gabrieli, E. R. // Clinical Pediatrics;Feb1967, Vol. 6 Issue 2, p74 

    The article discusses a study on the treatment of respiratory infections in children with methacycline. Methacycline is an antibiotic synthesized from oxytetracycline and possesses the broad antibiotic spectrum typical of the tetracyclines. Correlation of results of treatment with bacterial...

  • Antibiotic Susceptibility of Anaerobic Bacteria from the Human Oral Cavity. BAKER, P. J.; EVANS, R. T.; SLOTS, J.; GENCO, R. J. // Journal of Dental Research;Oct1985, Vol. 64 Issue 10, p1233 

    Anaerobic, agar-dilution, minimal inhibitory concentrations (MICs) of 18 antibiotics are given for the numerically important bacterial groups from the human oral cavity. Strains are divided into susceptibility categories using the guidelines for interpretation of MICs suggested by the National...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics